Related Experiment Videos
Mortality among triazine herbicide manufacturing workers
Paul A MacLennan1, Elizabeth Delzell, Nalini Sathiakumar
1School of Public Health, Department of Epidemiology and International Health, University of Alabama at Birmingham, 533 Ryals Building, 1665 University Boulevard, Birmingham, AL 35294-0022, USA. pmac@uab.edu
Journal of Toxicology and Environmental Health. Part A
|April 26, 2003
Summary
This study examined cancer mortality among workers at a triazine herbicide plant. While non-Hodgkin
Area of Science:
- Occupational Health
- Environmental Epidemiology
- Toxicology
Background:
- Atrazine is an endocrine modulator linked to mammary gland cancer in rats.
- Previous studies suggest associations between agricultural atrazine use and various cancers.
- Worker mortality patterns in herbicide manufacturing require investigation.
Purpose of the Study:
- To evaluate mortality patterns, specifically cancer, among workers at a triazine herbicide plant.
- To compare mortality rates of plant workers with the general population in the Louisiana industrial corridor.
Main Methods:
- A cohort study of 2213 workers employed at least 6 months between 1970-1997 in atrazine and triazine herbicide manufacturing/formulation.
- Vital status determination and standardized mortality ratios (SMRs) with 95% confidence intervals (CIs) were calculated.
- Mortality was compared to the Louisiana industrial corridor population, with 32,473 person-years of observation.
Main Results:
- Overall mortality was lower than expected (SMR = 72, CI = 57-89).
- Non-Hodgkin's lymphoma showed a significant increase in mortality (4 observed/1.1 expected, SMR = 372, CI = 101-952).
- Elevated SMRs were observed for digestive (SMR = 124, CI = 46-271) and lung cancers (SMR = 112, CI = 45-230), though data were sparse.
Conclusions:
- The study did not find causal evidence linking triazine herbicide manufacturing employment to overall or specific cancer mortality.
- Limitations include small study size, short follow-up, and lack of exposure data.
- The observed increase in non-Hodgkin's lymphoma warrants further investigation despite study limitations.